PT2115472E - Biomarcadores de cancro - Google Patents

Biomarcadores de cancro Download PDF

Info

Publication number
PT2115472E
PT2115472E PT78486313T PT07848631T PT2115472E PT 2115472 E PT2115472 E PT 2115472E PT 78486313 T PT78486313 T PT 78486313T PT 07848631 T PT07848631 T PT 07848631T PT 2115472 E PT2115472 E PT 2115472E
Authority
PT
Portugal
Prior art keywords
biomarcators
cancer
cancer biomarcators
Prior art date
Application number
PT78486313T
Other languages
English (en)
Portuguese (pt)
Inventor
Hardev Pandha
Richard George Leonard Morgan
Original Assignee
Univ Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Surrey filed Critical Univ Surrey
Publication of PT2115472E publication Critical patent/PT2115472E/pt

Links

Classifications

    • G01N33/57555—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PT78486313T 2006-12-19 2007-12-19 Biomarcadores de cancro PT2115472E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0625321.5A GB0625321D0 (en) 2006-12-19 2006-12-19 Cancer biomarker
GBGB0719792.4A GB0719792D0 (en) 2006-12-19 2007-10-10 Cancer biomarkers

Publications (1)

Publication Number Publication Date
PT2115472E true PT2115472E (pt) 2014-02-14

Family

ID=39265269

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78486313T PT2115472E (pt) 2006-12-19 2007-12-19 Biomarcadores de cancro

Country Status (19)

Country Link
US (1) US8460882B2 (show.php)
EP (1) EP2115472B1 (show.php)
JP (1) JP5683108B2 (show.php)
CN (1) CN101675341B (show.php)
AU (1) AU2007335999B2 (show.php)
BR (1) BRPI0720371B8 (show.php)
CA (1) CA2671939C (show.php)
CY (1) CY1115178T1 (show.php)
DK (1) DK2115472T3 (show.php)
ES (1) ES2445185T3 (show.php)
GB (2) GB0625321D0 (show.php)
IL (1) IL199241A (show.php)
MX (1) MX2009006378A (show.php)
NZ (1) NZ577548A (show.php)
PL (1) PL2115472T3 (show.php)
PT (1) PT2115472E (show.php)
RU (1) RU2460075C2 (show.php)
SI (1) SI2115472T1 (show.php)
WO (1) WO2008075056A1 (show.php)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461126B2 (en) 2005-10-14 2013-06-11 Phigenix, Inc. Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions
DE102006047617B4 (de) 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung basischer (Meth)acrylamide
DE102008017216B4 (de) 2008-04-04 2013-08-14 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
GB0823445D0 (en) * 2008-12-23 2009-01-28 Univ Surrey Biomarker
DE102009031059A1 (de) 2009-06-30 2011-01-05 Clariant International Ltd. Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
GB0912190D0 (en) * 2009-07-13 2009-08-26 Univ Surrey Biomarker
GB0912175D0 (en) * 2009-07-13 2009-08-26 Univ Surrey Biomarker
WO2011007130A1 (en) * 2009-07-13 2011-01-20 The University Of Surrey Therapeutic peptides, polypeptides ans nucleic acid sequences
DE102009042522A1 (de) 2009-09-22 2011-04-07 Clariant International Ltd. Kontinuierliches Umesterungsverfahren
DE102009042523B4 (de) 2009-09-22 2012-02-16 Clariant International Ltd. Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
GB0921329D0 (en) * 2009-12-04 2010-01-20 Univ Surrey Biomarker
DE102010056565A1 (de) 2010-12-30 2012-07-05 Clariant International Ltd. Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
US20140106363A1 (en) * 2011-05-12 2014-04-17 Noviogendix Research B.V. Molecular markers in prostate cancer
AU2012252426A1 (en) * 2011-05-12 2013-11-28 Noviogendix Research B.V. Molecular markers in prostate cancer
WO2013037118A1 (zh) * 2011-09-16 2013-03-21 上海长海医院 前列腺癌的生物学标志物、治疗靶点及其用途
WO2013085483A1 (en) * 2011-12-05 2013-06-13 Phigenix, Inc. Targeting en2, pax2, and/or defb1 for treatment of prostate conditions
US9110030B2 (en) 2012-06-29 2015-08-18 Daniel A. Kerschensteiner Colorimetric gelatinase assay
WO2014025961A1 (en) * 2012-08-10 2014-02-13 Analiza, Inc. Methods and devices for analyzing species to determine diseases
EP2994753B1 (en) * 2013-05-09 2018-03-07 The Procter and Gamble Company Method and system for assessing health condition
WO2016102560A1 (en) * 2014-12-23 2016-06-30 The University Of Surrey Glycosylated biomarker
KR101698654B1 (ko) * 2014-12-24 2017-01-20 포항공과대학교 산학협력단 En2에 특이적으로 결합하는 dna 압타머 및 이의 용도
WO2016193110A1 (en) * 2015-05-29 2016-12-08 Koninklijke Philips N.V. Methods of prostate cancer prognosis
ES2895154T3 (es) * 2015-09-23 2022-02-17 Centre Nat Rech Scient Engrailed para su uso en el tratamiento de daños en el ADN en un paciente que padece la enfermedad de Parkinson
CN106282347A (zh) * 2016-08-17 2017-01-04 中南大学 HoxC11作为生物标志物在制备肺腺癌的预诊断试剂中的应用
WO2018119715A1 (zh) * 2016-12-28 2018-07-05 中国科学院广州生物医药与健康研究院 一种获得t细胞的方法及应用
KR101777085B1 (ko) 2017-02-23 2017-09-11 주식회사 성균바이오텍 En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물
KR101777254B1 (ko) * 2017-07-14 2017-09-13 주식회사 무진메디 En2 단백질을 특이적으로 인식하는 특정 항원으로부터 얻어진 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물
KR101777259B1 (ko) 2017-07-14 2017-09-13 주식회사 무진메디 En2 단백질을 특이적으로 인식하는 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물
CN107727729A (zh) * 2017-11-22 2018-02-23 南宁科城汇信息科技有限公司 一种oa候选标志物诊断模型的建立方法
CN107894507A (zh) * 2017-11-22 2018-04-10 南宁科城汇信息科技有限公司 一种发现和鉴定肝癌血清差异表达蛋白和验证标志物蛋白方法
KR101923199B1 (ko) 2018-04-25 2018-11-28 주식회사 무진메디 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물
CN111363817B (zh) * 2018-12-26 2024-02-02 广州康立明生物科技股份有限公司 基于hoxd12基因的肺癌诊断剂及试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002510974A (ja) 1997-06-27 2002-04-09 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｎｋ−３関連前立腺特異的遺伝子−１
RU2234942C2 (ru) * 1998-07-14 2004-08-27 Корикса Корпорейшн Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид
WO2000023111A1 (en) * 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1290442B1 (en) 2000-05-30 2013-11-13 Aarhus Universitet An assay method for testing plant material for exposure to herbicides using biomarkers
WO2002000926A2 (en) * 2000-06-30 2002-01-03 Epigenomics Ag Diagnosis of diseases associated with signal transduction
AU2001292718A1 (en) * 2000-09-12 2002-03-26 Transgenetics Incorporated Microarrayed organization of transcription factor target genes
NZ527180A (en) 2000-12-24 2007-02-23 Iser Lubocki A method for detecting biomarkers
US20040063216A1 (en) 2000-12-24 2004-04-01 Iser Lubocki Method for detecting biomarkers
CA2439854A1 (en) * 2001-03-01 2002-09-12 Epigenomics Ag Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
US6949342B2 (en) * 2001-12-21 2005-09-27 Whitehead Institute For Biomedical Research Prostate cancer diagnosis and outcome prediction by expression analysis
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
US20060014301A1 (en) 2004-07-13 2006-01-19 Power3 Medical Products, Inc. Antibody-based system for detection of differential protein expression patterns
AU2005322435B2 (en) * 2004-12-02 2012-02-23 Epigenomics Ag Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
WO2006089091A2 (en) * 2005-02-18 2006-08-24 Memorial Sloan-Kettering Cancer Center Methods for detecting minimum residual disease

Also Published As

Publication number Publication date
CN101675341B (zh) 2017-08-08
MX2009006378A (es) 2009-08-24
SI2115472T1 (sl) 2014-05-30
DK2115472T3 (da) 2014-02-10
AU2007335999B2 (en) 2013-09-05
ES2445185T3 (es) 2014-02-28
RU2009127774A (ru) 2011-01-27
JP2010513901A (ja) 2010-04-30
AU2007335999A1 (en) 2008-06-26
GB0719792D0 (en) 2007-11-21
CY1115178T1 (el) 2016-12-14
WO2008075056A1 (en) 2008-06-26
IL199241A (en) 2014-03-31
EP2115472A1 (en) 2009-11-11
RU2460075C2 (ru) 2012-08-27
BRPI0720371B1 (pt) 2019-05-28
CA2671939C (en) 2017-10-03
US8460882B2 (en) 2013-06-11
GB0625321D0 (en) 2007-01-24
EP2115472B1 (en) 2013-11-06
NZ577548A (en) 2012-03-30
CA2671939A1 (en) 2008-06-26
BRPI0720371A2 (pt) 2013-12-31
US20100093558A1 (en) 2010-04-15
BRPI0720371B8 (pt) 2021-07-27
JP5683108B2 (ja) 2015-03-11
CN101675341A (zh) 2010-03-17
PL2115472T3 (pl) 2014-05-30

Similar Documents

Publication Publication Date Title
FIC20220006I1 (fi) Tafasitamabi
PT2115472E (pt) Biomarcadores de cancro
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
DK2096917T3 (da) Cyclopamin-analoger
DE602007006947D1 (de) Pyridopyrimidinonderivate
EP1996173A4 (en) Powder filling processes
DE602007009337D1 (de) Tastfeedbackvorrichtung
EP1996823A4 (en) CLAMP NUT
EP2077271A4 (en) Macrolide derivative
DK1984239T3 (da) Dobbeltlags-tørdragt
EP2091731A4 (en) LAMINATES OF PRE-PENSIONS
DE602007010359D1 (de) Azaspiroderivate
DE502007001629D1 (de) Rfahren
DE502007000218D1 (de) nsetzungen
FI20061014A0 (fi) Diffuusiopinnoitusmenetelmä
DE502007001652D1 (de) Notöltank
FI20060141A0 (fi) Viiluleikkuri
PT2444812E (pt) Métodos de imunoensaio melhorados
FI20065256A0 (fi) Lävistyspuristin
FI20065260A0 (fi) Vaihdemodulaattori
DE602006013286D1 (de) Sicherheitseinrictung
DE602007010028D1 (de) En
EP1984085A4 (en) SUSPENSION SYSTEM FOR SKI
FR2908431B1 (fr) Citerne-jardiniere
DE602007008212D1 (de) Tetomilast-polymorphe